http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2681539-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c979a0cca9409172f11f474dabd9f2b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42f352cc5bd193c17ffff15bf60e16f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4d33e45e5cbd64b8b893bd62ee22a85b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D295-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 |
| filingDate | 2011-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_198dc3fa37d29ab7cb73b402fe33f765 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbc17b5c67eeef79acb97737f0e6187e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_346601c8296333cf254bb63a6146c69a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0d72ca6f6b2cd9e0b8e6d95ce81f62e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2dfd6b41c858ce916ef995848be2db4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35da99dd8e241b3fb239e0a5409b0052 |
| publicationDate | 2018-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2681539-T3 |
| titleOfInvention | Useful compounds for the treatment of AIDS |
| abstract | A compound of formula (I) ** Formula ** wherein: X is CR0 or N, that is, together with the ring to which a benzene or pyridine group belongs respectively, R0, R1, R2, R3, R4, R7 and R8 independently represent a hydrogen atom, a halogen atom or a group selected from a (C1-C5) alkyl group, a (C3-C6) cycloalkyl group, a (C1-C5) fluoroalkyl group, a (C1-C5) group ) alkoxy, a (C1-C5) fluoroalkoxy group, a -CN group, a -COORa group, a -NO2 group, a - NRaRb group, a -NRa-SO2-NRaRb group, a -NRa-SO2-Ra group, a group -NRa-C (> = O) -Ra-, a group -NRa-C (> = O) -NRa-Rb, a group -SO2-NRaRb, a group -SO3H, a group -OH, a group -O-SO2-ORc, a group -OP (> = O) -) ORc) (ORd), a group -O-CH2-COORc and can additionally be a group selected from: ** Formula ** A is a link covalent, an oxygen atom or NH, B is a covalent bond or NH, n is 1, 2, 3, 4 or 5, m is 1, 2 or 3, R, R ', Ra and Rb independently represent an atom of hydrogen, a group or (C1-C5) alkyl or a (C3-C6) cycloalkyl group, R and R 'may subsequently form together with the nitrogen atom to which a saturated 5 or 6 membered heterocycle is attached which optionally contains an additional heteroatom selected from N, O and S, said heterocycle being optionally substituted with one or more R, Rc and Rd independently represent a hydrogen atom, Li +, Na +, K +, N + (Ra) 4 or a benzyl group, R5 represents a hydrogen atom, a (C1-C5) alkyl group or a (C3-C6) cycloalkyl group, R10 is a hydrogen atom or a chlorine atom, and R11 is a hydrogen atom a (C1-C4) alkyl group, or any one of its pharmaceutically acceptable salts, with the proviso that at least three of R5, R7, R8 and R10 are different from a hydrogen atom, or alternatively with the proviso that one of R7 and R8 is a group selected from ** Formula * *, a group -NRa-SO2-NRaRb, a group -NRa-SO2-Ra, a group -NRa-C (> = O) -Ra and a group -NRa -C (> = O) -RaRb, where R, R ', A, B, Ra, Rb, n and m are as defined above, and the other of R7 and R8 is a hydrogen atom, or alternatively with the condition of which one of R0, R1, R2, R3 and R4 is a group selected from ** Formula ** a group -NRa-SO2-NRaRb, a group -NRa-SO2-Ra, a group -NRa-C (> = O) -Ra and a group -NRa-C (> = O) -NRaRb where R, R ', A, B, Ra, Rb, n and m are as defined above, for use as in a method for prevention, inhibition or treatment of AIDS. |
| priorityDate | 2010-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 230.